Paper39891992
Novel biallelic ADCY10 variants cause asthenozoospermia with excessive residual cytoplasm and hydronephrosis in humans.
Zeb A and 14 others. Reprod Biomed Online, 2025. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. Novel biallelic ADCY10 variants cause asthenozoospermia with excessive residual cytoplasm and hydronephrosis in humans. Papers, record 39891992. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39891992
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Novel biallelic ADCY10 variants cause asthenozoospermia with excessive residual cytoplasm and hydronephrosis in humans.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Asthenozoospermia | Major topic |
| Adenylyl Cyclases | Major topic |
| Hydronephrosis | Major topic |
| Cytoplasm | Major topic |
| Humans | |
| Male | |
| Adult | |
| Pedigree | |
| Spermatozoa | |
| Mutation | |
| Alleles |
Source PubMed
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42241232 | Assessing efficacy of ADCY10 inhibitors in cervical mucus. | Mol Hum Reprod | 2026 | https://conductscience.org/library/papers/42241232 | PubMed |
| 41843491 | Targeting Soluble Adenylyl Cyclase for On-Demand Contraception. | Physiology (Bethesda) | 2026 | https://conductscience.org/library/papers/41843491 | PubMed |
| 41591904 | Soluble adenylyl cyclase in nonmammalian sperm is directly controlled by pH, not by HCO3- or Ca2. | Proc Natl Acad Sci U S A | 2026 | https://conductscience.org/library/papers/41591904 | PubMed |
| 41247380 | Sustained soluble adenylyl cyclase (sAC)-generated cAMP is necessary and sufficient for hyperactivated motility in human sperm. | Hum Reprod | 2026 | https://conductscience.org/library/papers/41247380 | PubMed |
| 41197733 | Biochemical characterization of the full-length isoform of soluble adenylyl cyclase. | J Biol Chem | 2025 | https://conductscience.org/library/papers/41197733 | PubMed |
| 40799474 | Fertility test of mice (Mus musculus). | Bio Protoc | 2025 | https://conductscience.org/library/papers/40799474 | PubMed |
| 40457935 | A novel frameshift variant in AXDND1 may cause multiple morphological abnormalities of the sperm flagella in a consanguineous Pakistani family. | Asian J Androl | 2025 | https://conductscience.org/library/papers/40457935 | PubMed |
| 40320899 | Bovine serum albumin-induced calcium influx triggers soluble adenylyl cyclase activation and cyclic AMP signalling pathways in mouse sperm capacitation. | J Physiol | 2025 | https://conductscience.org/library/papers/40320899 | PubMed |
| 40003956 | Cyclic AMP Rescue of Motility in Sperm Devoid of Soluble Adenylyl Cyclase. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40003956 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ADCY10 | 55811 | PubTator's text mining | https://conductscience.org/library/genes/55811 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39891992
GET https://conductscience.org/api/papers/v1/39891992/authors